Longitudinal assessment of bleomycin-induced lung fibrosis by Micro-CT correlates with histological evaluation in mice

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2049-6958
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Longitudinal assessment of bleomycin-induced lung fibrosis by Micro-CT correlates with histological evaluation in mice ; volume:12 ; number:1 ; day:10 ; month:4 ; year:2017 ; pages:1-10 ; date:12.2017
Multidisciplinary respiratory medicine ; 12, Heft 1 (10.4.2017), 1-10, 12.2017

Schlagwort
Atemwegskrankheit
Atemnot

Urheber
Ruscitti, Francesca
Beteiligte Personen und Organisationen
Ravanetti, Francesca
Essers, Jeroen
Ridwan, Yanto
Belenkov, Sasha
Vos, Wim
Ferreira, Francisca
KleinJan, Alex
van Heijningen, Paula
Van Holsbeke, Cedric
Cacchioli, Antonio
Villetti, Gino
Stellari, Franco Fabio
SpringerLink (Online service)

DOI
10.1186/s40248-017-0089-0
URN
urn:nbn:de:1111-201704273062
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:34 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Ruscitti, Francesca
  • Ravanetti, Francesca
  • Essers, Jeroen
  • Ridwan, Yanto
  • Belenkov, Sasha
  • Vos, Wim
  • Ferreira, Francisca
  • KleinJan, Alex
  • van Heijningen, Paula
  • Van Holsbeke, Cedric
  • Cacchioli, Antonio
  • Villetti, Gino
  • Stellari, Franco Fabio
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Plumbagin attenuates Bleomycin-induced lung fibrosis in mice

Plumbagin attenuates Bleomycin-induced lung fibrosis in mice

Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis

Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis

Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ

Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ

Bleomycin-induced genome structural variations in normal, non-tumor cells

Bleomycin-induced genome structural variations in normal, non-tumor cells

Supramolecular Nanofibers Ameliorate Bleomycin‐Induced Pulmonary Fibrosis by Restoring Autophagy

Supramolecular Nanofibers Ameliorate Bleomycin‐Induced Pulmonary Fibrosis by Restoring Autophagy

A critical role of AREG for bleomycin-induced skin fibrosis

A critical role of AREG for bleomycin-induced skin fibrosis

Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice

Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice

Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis

Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis

Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis

Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis

Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice

Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice

Gut microbiota modulates bleomycin-induced acute lung injury response in mice

Gut microbiota modulates bleomycin-induced acute lung injury response in mice

Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis

Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis

Verbundene Objekte